Solazyme's first commercial application of its algae-based oil will be a facial treatment rather than the renewable biofuel it eventually hopes to bring to market. The company's strategy is to create products that will help it remain financially viable as it finds a way to produce enough fuel to be competitive. Meanwhile, Solazyme and Roquette announced they are ending their microalgae joint venture, Solazyme Roquette Nutritionals, due to differences of opinion on marketing and manufacturing.

Related Summaries